Evidence Analysis

It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.

Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:

  • Does the technology improve health outcomes?
  • Are there other benefits associated with the technology?
  • What harms might be associated with the technology?
  • Have patient selection criteria been established for the technology?
  • For which patients might the technology provide a benefit?

Intraoperative Neuromonitoring for Lumbar Spinal Fusion and Discectomy

Focus of Report: This report focuses on intraoperative neuromonitoring (IONM) for the detection and prevention of surgical manipulations that could cause nerve damage during lumbar spinal discectomy alone or discectomy plus fusion.

Technology Description: During discectomy or fusion of…

LUKE Arm (Mobius Bionics LLC) for Upper Extremity Amputation

Focus of the Report: This health technology assessment focuses on the efficacy and safety of the life under kinetic evolution (LUKE) arm (Mobius Bionics) for adults with upper extremity (or limb) amputation.

Technology Description: Developed by DEKA Research and Development Corporation…

Intravascular Lithotripsy for Calcified Peripheral Arterial Lesions

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of intravascular lithotripsy (IVL) for treatment of calcified arteries in patients with peripheral artery disease (PAD).

Subchondral Calcium Phosphate Injections for Knee Bone Marrow Lesions

This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of subchondral calcium phosphate (SCP) injections for the treatment of pain and function impairment due to bone marrow lesions (BMLs) associated with knee osteoarthritis (KOA) and/or insufficiency fractures.